Clinical trial
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
NCT00005047 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00005047 |
|---|---|
| Title | 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer |
| Official title | MVAC (Methotrexate, Vinblastine, Adriamycin, and Cisplatin) in Organ-Confined Bladder Cancer Based on p53 Status |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group University of Southern California |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, doxorubicin hydrochloride, methotrexate, vinblastine |
| Enrollment | 521 |
| Start date | Aug 1, 1997 |
| Primary completion | Mar 1, 2011 |
| Completion | Dec 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 8, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: